The diMARIE study is being conducted at the University Hospital Würzburg. Oncosia Scientific provides the medical software OncoPrevia.
The early detection of cancer has been proven to improve chances of recovery and quality of life. In our study, we are testing a new digital solution for risk stratification based on medical S3 guidelines, combined with structured informational consultations. The goal is to derive individual recommendations for cancer prevention and early detection – directly at the general practitioner or specialist.
Every person has a unique risk profile. With OncoPrevia, we raise awareness of personal risk factors – evidence-based, easy to understand, and scientifically grounded.
Clear and respectful communication creates confidence: With personalized recommendations and easy-to-understand reports, we promote participation in relevant early detection measures.
OncoPrevia adapts to everyday clinical routines – not the other way around. Without technical barriers, our software supports medical professionals in effectively implementing cancer prevention.
To ensure the secure processing of your data, you will receive a personal participant ID for the diMARIE study. You can request it directly through the web application or via this link: Get Participant-ID
With your ID and the password provided to you, you can easily log in to our web application OncoPrevia.
Immediately after logging in, you will receive all essential information about the study – clearly explained through video and informational material. If you agree, you can confirm your participation right away.
Still have questions? We’re here for you – via email, phone, or an online appointment. (Contact information below)
In the next step, you will answer questions about: general information, personal medical history, family history of cancer, and risk factors. Completing the questionnaires takes about 15–20 minutes and can be saved to finish later.
About one week after completing your information, we will schedule an online or telephone consultation with you. Together, we will discuss your results and answer your questions.
Afterward, we will ask you to participate in a short scientific interview as part of the study.
Four weeks later, we would like to speak with you again. The goal is to better understand how you have processed the information and how we can further improve the communication.
+49 (0) 160 96255919
Send us a message on WhatsApp or call us directly
Talk to one of our experts about your concerns and get initial information.
Oncosia Scientific GmbH
mail@oncosia.de
+49 (0) 160 96255919
© 2025 Oncosia Scientific GmbH. All rights reserved